Lispro NL-ELISA

(10-1291-01)

Kit format: 1×96 wells

Measurement range: 1 - 500 mU/L

1.Optimized for pharma use

2.No cross-reactivity to endogenous insulin or other insulin analogs e.g. glargine

3.No interference from insulin auto-antibodies

4.Fully validated for use with human and pig samples, partially validated for rat samples

5.Controls included in the kit

DESCRIPTION

Mercodia Lispro NL-ELISA is designed to be an excellent assay for pharma use.

It provides a chemiluminescent method for the quantitative determination of insulin lispro. The kit includes six calibrators, two anchor points and controls in serum matrix. Validation data available.

TEST CHARACTERISTICS

SPECIES：Human and Porcine

SAMPLES：Serum, EDTA plasma and P-800 plasma

SAMPLE VOLUME：10 µL

ASSAY RANGE：1 - 500 mU/L

DETECTION LIMIT：≤0.36 mU/L

INCUBATION：1h + 1h + 10 min

DETECTION METHOD：Chemiluminescence

SPECIFICITY

The following cross-reactions have been tested:

HUMAN INSULIN：Not detected

HUMAN PROINSULIN：Not detected

GLARGINE：Not detected

GLARGINE M1：Not detected

GLARGINE M2：Not detected

DEGLUDEC：Not detected

DETERMIR：Not detected

INSULIN NPH：Not detected

ASPART：Not detected

GLULISINE：Not detected

PORCINE INSULIN：Not detected

PORCINE PROINSULIN：Not detected